<doc>
  <docmeta id="113s1323is">
    <bill congress="113" type="s" number="1323" version="is"/>
    <revision size="11734" annotations="0" status="complete" id="8" commit-time="2013-08-22T23:07:15Z" committer="mbohmer" doc="113s1323is/8.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 S1323 IS: Protecting Our Youth from Dangerous Synthetic Drugs Act of 2013</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2013-07-18</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 1323</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20130718">July 18, 2013</action-date>
			<action-desc>
        <sponsor name-id="S221">Mrs. Feinstein</sponsor> (for
			 herself, <cosponsor name-id="S311">Ms. Klobuchar</cosponsor>,
			 <cosponsor name-id="S338">Mr. Manchin</cosponsor>, and
			 <cosponsor name-id="S270">Mr. Schumer</cosponsor>) introduced the following
			 bill; which was read twice and referred to the
			 <committee-name committee-id="SSJU00">Committee on the
			 Judiciary</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To address the continued threat posed by dangerous
		  synthetic drugs by amending the Controlled Substances Act relating to
		  controlled substance analogues.</official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one">
      <enum>1.</enum>
      <header>Short
			 title</header>
      <text display-inline="no-display-inline">This Act may be cited as
			 the <quote>
          <short-title>Protecting Our Youth from
			 Dangerous Synthetic Drugs Act of 2013</short-title>
        </quote>.</text>
		</section>
    <section id="id2008687D63C540DEB0E696A58A9274EC">
      <enum>2.</enum>
      <header>Enforcement</header>
			<subsection id="idC6D5B00BD4FA4C1C9695E21D268663A3">
        <enum>(a)</enum>
        <header>In
			 general</header>
        <text display-inline="yes-display-inline">The <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Controlled Substances Act">Controlled
			 Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/801">
              <cato:entity-ref entity-type="uscode" value="usc/21/801/etseq">21 U.S.C. 801 et seq.</cato:entity-ref>
            </external-xref>)</cato:entity> is amended—</text>
				<paragraph id="id6070A89960754965B7F282986FFEF307">
          <enum>(1)</enum>
          <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:102/p:32">section
			 102(32)</cato:entity-ref>, by striking <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:102/p:32/sp:A">subparagraph (A)</cato:entity-ref> and inserting the following:</text>
					<quoted-block display-inline="no-display-inline" id="id2C61F76770744B8F9EC25D17CF2EFA42" style="OLC">
						<subparagraph id="id7D4F2F94B88246E7850ADB9F2D896A1B" indent="up1">
              <enum>(A)</enum>
              <text>Except as provided in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:102/p:32/sp:C">subparagraph
				(C)</cato:entity-ref>, the term <term>controlled substance analogue</term> means—</text>
							<clause id="idf797eedc4a244152823c7ed913ec5844">
                <enum>(i)</enum>
                <text>a substance whose chemical
				structure is substantially similar to the chemical structure of a controlled
				substance in schedule I or II—</text>
								<subclause id="idf9841faaa1b4449fb0a326a948685607">
                  <enum>(I)</enum>
                  <text>which has a stimulant, depressant, or
				hallucinogenic effect on the central nervous system that is substantially
				similar to or greater than the stimulant, depressant, or hallucinogenic effect
				on the central nervous system of a controlled substance in schedule I or II;
				or</text>
								</subclause>
                <subclause id="idea562de49ca44e12b812df0c5c006f43">
                  <enum>(II)</enum>
                  <text>with respect to a particular person,
				which such person represents or intends to have a stimulant, depressant, or
				hallucinogenic effect on the central nervous system that is substantially
				similar to or greater than the stimulant, depressant, or hallucinogenic effect
				on the central nervous system of a controlled substance in schedule I or II;
				or</text>
								</subclause>
              </clause>
              <clause id="idC734FB73A297402E86508E1A8FF0E411">
                <enum>(ii)</enum>
                <text>a substance designated as a
				controlled substance analogue by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Controlled Substance Analogue Committee</cato:entity-ref> in
				accordance with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:201/ss:i" proposed="true">section 201(i)</cato:entity-ref>.</text>
							</clause>
            </subparagraph>
            <after-quoted-block>;
				and</after-quoted-block>
          </quoted-block>
				</paragraph>
        <paragraph id="id1D2055D80BD8433EB8F8CD57346A4176">
          <enum>(2)</enum>
          <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:201">section 201</cato:entity-ref>,
			 by adding at the end the following:</text>
					<quoted-block display-inline="no-display-inline" id="id7B6AF1540A124392B0D33FA7AF212DDE" style="OLC">
						<subsection id="id60CF5AB3377F43EEAA7D39B7D8467108">
              <enum>(i)</enum>
              <paragraph commented="no" display-inline="yes-display-inline" id="id908D960EC0D04866843BA45AFBD19D4C">
                <enum>(1)</enum>
                <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1500">Attorney General</cato:entity-ref>,
				in consultation with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human Services</cato:entity-ref>, shall
				establish an interagency committee, to be known as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Controlled Substance
				Analogue Committee</cato:entity-ref> (referred to in this subsection as the
				<quote>
                    <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref>
                  </quote>).</text>
							</paragraph>
              <paragraph id="idF9DBB534CAC6457988FBD7CF6C778182" indent="up1">
                <enum>(2)</enum>
                <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref> shall be—</text>
								<subparagraph id="id7C3D94F6BB2043B7856DBAD9A712DCC5">
                  <enum>(A)</enum>
                  <text>headed by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1524">Administrator of the
				Drug Enforcement Administration</cato:entity-ref>; and</text>
								</subparagraph>
                <subparagraph id="id37453C3B7B554845A40E98AB13195BB4">
                  <enum>(B)</enum>
                  <text>comprised of scientific experts in the
				fields of chemistry and pharmacology from—</text>
									<clause id="id69F1DD4CE43B4A9E9D96F9F6304C9480">
                    <enum>(i)</enum>
                    <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1524">Drug Enforcement
				Administration</cato:entity-ref>;</text>
									</clause>
                  <clause id="id7B5D5C1B8F7A40C79759E36B5F133F88">
                    <enum>(ii)</enum>
                    <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="National Institute on Drug Abuse" entity-parent-id="7529">National Institute on Drug
				Abuse</cato:entity-ref>;</text>
									</clause>
                  <clause id="id2ACC7910DE75466C84973BABD1AFEDE7">
                    <enum>(iii)</enum>
                    <text>the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7523">Centers for
			 Disease Control and Prevention</cato:entity-ref>; and</text>
									</clause>
                  <clause id="id783F7D4DB6584DCEBAC5D13F5D21A753">
                    <enum>(iv)</enum>
                    <text>any other Federal agency
				determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1500">Attorney General</cato:entity-ref>, in consultation with the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of
				Health and Human Services</cato:entity-ref>, to be appropriate.</text>
									</clause>
                </subparagraph>
              </paragraph>
              <paragraph id="id49483F5929534D5D9A71A88A7CB198E3" indent="up1">
                <enum>(3)</enum>
                <subparagraph commented="no" display-inline="yes-display-inline" id="id8B3379C9D38C4268A8D2180952B0BAC8">
                  <enum>(A)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref> shall
				convene, on an as needed basis, to establish and maintain a list of controlled
				substance analogues.</text>
								</subparagraph>
                <subparagraph id="idA9EEC7AC3B484016A93E8EFAED132224" indent="up1">
                  <enum>(B)</enum>
                  <text>A substance may be designated as a
				controlled substance analogue by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref> under this subsection if the
				substance is determined by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref> to be similar to a schedule I or II
				controlled substance in either its chemical structure or its predictive effect
				on the body, in such a manner as to make it likely that the substance will, or
				can be reasonably expected to have a potential for abuse.</text>
								</subparagraph>
                <subparagraph id="idA86F7E8D431B450FAB2D5B391350A864" indent="up1">
                  <enum>(C)</enum>
                  <text>Evidence of human consumption by an
				individual or the public at large is not necessary before a substance may be
				designated as a controlled substance analogue under this subsection.</text>
								</subparagraph>
                <subparagraph id="idB9CE377AA1054503A7D4F2EF806A0EC8" indent="up1">
                  <enum>(D)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1500">Attorney General</cato:entity-ref> shall, through
				rulemaking, establish procedures of operation for the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref>.</text>
								</subparagraph>
              </paragraph>
              <paragraph id="idAEDFE182C04E4847B7220D26B7554D49" indent="up1">
                <enum>(4)</enum>
                <subparagraph commented="no" display-inline="yes-display-inline" id="id834FE493F4BD4600BFC2636C4DA67DC8">
                  <enum>(A)</enum>
                  <text>Not later than 30 days
				before each meeting of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1500">Attorney General</cato:entity-ref> shall submit to the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human Services</cato:entity-ref> a notice of the meeting of the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref>, which shall include—</text>
									<clause id="id87457440C7C3456C86EC0A083ED61249" indent="up1">
                    <enum>(i)</enum>
                    <text>a list of the substances to be
				considered by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref> during the meeting for designation as a controlled
				substance analogue; and</text>
									</clause>
                  <clause id="id13B76B37763347808D7020478E68A147" indent="up1">
                    <enum>(ii)</enum>
                    <text>a request for the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health
				and Human Services</cato:entity-ref> to make a determination of whether an exemption or approval
				for each substance listed under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:201/ss:i/p:4/sp:A/cl:i" proposed="true">clause (i)</cato:entity-ref> is in effect under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                        <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:505">section 505 of
				the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/355">
                          <cato:entity-ref entity-type="uscode" value="usc/21/355">21 U.S.C. 355</cato:entity-ref>
                        </external-xref>)</cato:entity>.</text>
									</clause>
                </subparagraph>
                <subparagraph id="id87ABA88FB00C421ABDE553CDD4941087" indent="up1">
                  <enum>(B)</enum>
                  <text>Not later than 30 days after the date
				on which the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human Services</cato:entity-ref> receives notice under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:201/ss:i/p:4/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary</cato:entity-ref> shall submit to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1500">Attorney General</cato:entity-ref> a written
				response to the request described under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:201/ss:i/p:4/sp:A/cl:ii" proposed="true">subparagraph (A)(ii)</cato:entity-ref>. The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref>
				shall consider the response submitted by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human
				Services</cato:entity-ref> in determining whether to designate a substance considered by the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref> at the meeting as a controlled substance analogue.</text>
								</subparagraph>
              </paragraph>
              <paragraph id="idA8073704B72A49C18B8F7853FA7686CA" indent="up1">
                <enum>(5)</enum>
                <subparagraph commented="no" display-inline="yes-display-inline" id="id57DF259EB1314BF999ECBEDE1FD0185E">
                  <enum>(A)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1500">Attorney General</cato:entity-ref>
				shall publish in the Federal Register any designation made by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref>
				under this subsection.</text>
								</subparagraph>
                <subparagraph id="id6B4D22FCBB12484E8A116CD4B3236ED8" indent="up1">
                  <enum>(B)</enum>
                  <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1524">Administrator of the Drug
				Enforcement Administration</cato:entity-ref> shall publish, on the website of the Drug
				Enforcement Administration, a description of each designation made by the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref> under this subsection, which shall include—</text>
									<clause id="id8405A18A419B4061B678D6120ACCEF18">
                    <enum>(i)</enum>
                    <text>the chemical and common name of the
				controlled substance analogue;</text>
									</clause>
                  <clause id="idF904CB65FDDB4A95A2A3D0595D377E38">
                    <enum>(ii)</enum>
                    <text>the effective date of the
				determination, as described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:201/ss:i/p:6/sp:A" proposed="true">paragraph (6)(A)</cato:entity-ref>; and</text>
									</clause>
                  <clause id="id0F42916BE9644882B6DFE9CE1F35257C">
                    <enum>(iii)</enum>
                    <text>any schedule I or II controlled
				substance that the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref> has determined a substance is an analogue
				of.</text>
									</clause>
                </subparagraph>
              </paragraph>
              <paragraph id="idA06C8D818F6A43CF91BFA245B5AB1BA5" indent="up1">
                <enum>(6)</enum>
                <text>A designation made by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref>
				under this subsection shall take effect on the date that is 30 days after the
				date on which the designation is published in the Federal Register under
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:201/ss:i/p:5/sp:A" proposed="true">paragraph (5)(A)</cato:entity-ref>.</text>
							</paragraph>
              <paragraph id="idE4C9408110154D5B94DABED3DD12EEE3" indent="up1">
                <enum>(7)</enum>
                <text>If a substance designated as a
				controlled substance analogue by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref> under this section is
				subsequently scheduled through a rulemaking proceeding under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:201/ss:a">subsection (a)</cato:entity-ref>,
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:201/ss:d">(d)</cato:entity-ref>, or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Act/s:201/ss:h">(h)</cato:entity-ref>, the substance shall be automatically removed from the controlled
				substance analogue list.</text>
							</paragraph>
              <paragraph id="idF8B183CE1D244102B58B4704896981A8" indent="up1">
                <enum>(8)</enum>
                <text>If a defendant challenges the
				designation of a controlled substance analogue made by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Controlled Substance Analogue Committee" proposed="true">Committee</cato:entity-ref> under this
				subsection the issue shall be considered a question of
				law.</text>
							</paragraph>
            </subsection>
            <after-quoted-block>.</after-quoted-block>
          </quoted-block>
				</paragraph>
      </subsection>
      <subsection id="id2F8305E0FC9F4EB6BD03E5AE39CDED93">
        <enum>(b)</enum>
        <header>Funding</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="public-law" value="public-law/102/395/s:111/ss:b/p:2/sp:B">Section
			 111(b)(2)(B) of <external-xref legal-doc="public-law" parsable-cite="pl/102/395">Public Law 102–395</external-xref>
            </cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/886a">
              <cato:entity-ref entity-type="uscode" value="usc/21/886a//2/B">21 U.S.C. 886a(2)(B)</cato:entity-ref>
            </external-xref>)</cato:entity> is amended by
			 inserting <quote>controlled substance analogues,</quote> after
			 <quote>substances,</quote>.</text>
			</subsection>
    </section>
    <section id="id19FBADED53A04E67983F0B36F1D8DDBF">
      <enum>3.</enum>
      <header>Importation of
			 controlled substance analogues</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Controlled Substances Import and Export Act/s:1002">Section 1002 of the Controlled Substances
			 Import and Export Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/952">
            <cato:entity-ref entity-type="uscode" value="usc/21/952">21 U.S.C. 952</cato:entity-ref>
          </external-xref>)</cato:entity> is amended—</text>
			<paragraph id="id6E7D2014487A4E858B46EEE686FB3D9E">
        <enum>(1)</enum>
        <text>by redesignating
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Import and Export Act/s:1002/ss:c..e">subsections (c) through (e)</cato:entity-ref> as <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Import and Export Act/s:1002/ss:d..f" proposed="true">subsections (d) through (f)</cato:entity-ref>, respectively;
			 and</text>
			</paragraph>
      <paragraph id="idA50648C2207F4DD9960B77B1559272EB">
        <enum>(2)</enum>
        <text>by inserting
			 after <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Controlled Substances Import and Export Act/s:1002/ss:b">subsection (b)</cato:entity-ref> the following:</text>
				<quoted-block display-inline="no-display-inline" id="id0B4C051427E640B78CE83A89D83E8785" style="OLC">
					<subsection id="id3140211C4EB94886B5545955453D3892">
            <enum>(c)</enum>
            <text>It shall be
				unlawful to import into the customs territory of the United States from any
				place outside thereof (but within the United States), or to import into the
				United States from any place outside thereof, any controlled substance analogue
				designated pursuant to <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                <cato:entity-ref entity-type="act" value="Controlled Substances Act/s:201/ss:i">section 201(i) of the Controlled Substances Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/811/i">21
				U.S.C. 811(i)</cato:entity-ref>)</cato:entity> unless the controlled substance analogue is imported pursuant to
				such notification or declaration as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1500">Attorney General</cato:entity-ref> may by regulation
				prescribe.</text>
					</subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</paragraph>
    </section>
    <section id="id0051B7FD54E34DB2A2FF16422F4B778B">
      <enum>4.</enum>
      <header>Directive to
			 Sentencing Commission</header>
			<subsection id="id6417b965150f414aa84a26bef1855cce">
        <enum>(a)</enum>
        <header>In
			 general</header>
        <text>Pursuant to its authority under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/28/994">
            <external-xref legal-doc="usc" parsable-cite="usc/28/994">section 994</external-xref> of title 28,
			 United States Code</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1030">United States Sentencing Commission</cato:entity-ref> shall review and,
			 if appropriate, amend the Federal sentencing guidelines and policy statements
			 to ensure the guidelines and policy statements provide adequate penalties for
			 any offense involving the unlawful manufacturing, importing, exporting, or
			 trafficking of controlled substance analogues under <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Controlled Substances Act/pt:D">part D of the Controlled
			 Substances Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/841">
              <cato:entity-ref entity-type="uscode" value="usc/21/841/etseq">21 U.S.C. 841 et seq.</cato:entity-ref>
            </external-xref>)</cato:entity> or <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Controlled Substances Import and Export Act/pt:A">part A of the Controlled Substances
			 Import and Export Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/951">
              <cato:entity-ref entity-type="uscode" value="usc/21/951/etseq">21 U.S.C. 951 et seq.</cato:entity-ref>
            </external-xref>)</cato:entity> and similar offenses, including
			 unlawful possession, possession with intent to commit any of the foregoing
			 offenses, and attempt and conspiracy to commit any of the foregoing
			 offenses.</text>
			</subsection>
      <subsection id="id140980dd568344f19ebf490454814ff7">
        <enum>(b)</enum>
        <header>Commission
			 duties</header>
        <text>In carrying out this section, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1030">Sentencing Commission</cato:entity-ref>
			 shall—</text>
				<paragraph id="id971e86a1c9a1490c94113f95c210c410">
          <enum>(1)</enum>
          <text>ensure that the
			 sentences, guidelines, and policy statements relating to offenders convicted of
			 these offenses are appropriately severe and reasonably consistent with other
			 relevant directives and other Federal sentencing guidelines and policy
			 statements;</text>
				</paragraph>
        <paragraph id="id53409e810ce8433f991cbe1950be73d0">
          <enum>(2)</enum>
          <text>make any
			 necessary conforming changes to the Federal sentencing guidelines; and</text>
				</paragraph>
        <paragraph id="id6564fda7336f4697a4b6b2f3992f019f">
          <enum>(3)</enum>
          <text>assure that the
			 guidelines adequately meet the purposes of sentencing as set forth in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/18/3553/a/2">section
			 3553(a)(2) of title 18, United States Code</cato:entity-ref>.</text>
				</paragraph>
      </subsection>
    </section>
  </legis-body>
</bill>
</doc>